2006
DOI: 10.1016/j.ijcard.2005.06.006
|View full text |Cite
|
Sign up to set email alerts
|

Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
96
0
3

Year Published

2007
2007
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 100 publications
(105 citation statements)
references
References 41 publications
6
96
0
3
Order By: Relevance
“…Studies have shown that CHF is associated with reduced skeletal muscle strength per unit muscle size (9,28). This contractile deficit at the whole muscle level has been observed in isolated muscle tissue in animal models (16,21) and in chemically skinned, single muscle fibers in humans (26), suggesting that the heart failure syndrome promotes contractile dysfunction at the level of the myofilaments.…”
Section: Discussionmentioning
confidence: 98%
See 2 more Smart Citations
“…Studies have shown that CHF is associated with reduced skeletal muscle strength per unit muscle size (9,28). This contractile deficit at the whole muscle level has been observed in isolated muscle tissue in animal models (16,21) and in chemically skinned, single muscle fibers in humans (26), suggesting that the heart failure syndrome promotes contractile dysfunction at the level of the myofilaments.…”
Section: Discussionmentioning
confidence: 98%
“…Written, informed consent was obtained from each research subject. Data on these volunteers regarding the effect of heart failure on skeletal muscle protein expression and whole muscle function have been published previously (27,28).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…This underlies the "skeletal muscle hypothesis" of exercise intolerance in CHF (Clark et al, 1996). However, most studies addressing the "skeletal muscle hypothesis" in humans have focused primarily on isolated skeletal muscle, including histology, biochemistry (Sullivan et al, 1990), morphology Panizzolo et al, 2014) and strength (Lipkin et al, 1988;Toth et al, 2006). It is likely that these factors all contribute to some extent to reduced functional walking performance in CHF.…”
Section: Introductionmentioning
confidence: 99%
“…In addition to contributing to the pathophysiology and the progression of structural and functional changes in the heart muscle, these inflammatory mediators may directly lead to peripheral manifestations of the HF syndrome, especially in those changes related to a decrease in muscle mass and functional changes 10,11 , among others.…”
Section: Introductionmentioning
confidence: 99%